US Patent Issued to Escient Pharmaceuticals on Aug. 12 for "Modulators of mas-related g-protein receptor X2 and related products and methods" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,748, issued on Aug. 12, was assigned to Escient Pharmaceuticals Inc. (San Diego).

"Modulators of mas-related g-protein receptor X2 and related products and methods" was invented by Marion Lanier (San Diego), Marcus Boehm (San Diego), Liming Huang (San Diego), Esther Martinborough (San Diego), Marcos Sainz (San Diego), Brandon Selfridge (San Diego) and Adam Yeager (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for modulating MRGPR X2 generally, or for treating a MRGPR X2 dependent condition more specifically, by contacting the MRGPR X2 or administering to a subject in need thereof, respectively, an effective amount of ...